- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
12 Drugs Approved for Primary Care in 2019
ICYMI: Get a quick look at 12 of the many drugs FDA-approved in 2019 for conditions commonly seen in primary care.
New drugs were approved for many conditions commonly treated in primary care in all 4 quarters in 2019 - quite a few of them first-in-class or novel in another way: The first liquid solution of colchicine for gout The first generic Advair Diskus inhaler for asthma and COPD A novel weight-loss drug that is the first approved for BMI as low as 25 25 kg/m2 The first generic naloxone spray The first oral GLP-1 receptor agonist and a glucagon nasal spray for hypoglycemiaIn the spirit of the holiday, we highlight 12 of the 2019 FDA approvals to prep primary care clinicians for 2020.
Roche, Alnylam Advance Zilebesiran Into Phase 3 CV Outcomes Trial for Resistant Hypertension
September 9th 2025Zilebesiran’s twice-yearly dosing and sustained BP reductions could offer a new therapeutic approach for adults with resistant hypertension and high CV risk who are uncontrolled on current SOC regimens.
